DEPRESSION OF CYTOCHROME-P-450-DEPENDENT DRUG BIOTRANSFORMATION BY ADRIAMYCIN

The cytochrome P-450-dependent mixed function oxidase system was depressed following the administration of [the antineoplastic drug] adriamycin. Cytochrome P-450, aminopyrine N-demethylase and benzo(a)pyrene hydroxylase were significantly decreased in hepatic microsomes prepared from rats treated with a single dose of adriamycin (10 mg/kg s.c.) 4 days previously. Total microsomal protein levels and cytochrome b5 levels remained unchanged. The administration of cysteamine 1 h prior to adriamycin prevented the loss of the cytochrome P-450 and the decrease in drug biotransformation. The administration of diethylmaleate had no effect on the ability of adriamycin to decrease this enzyme system. The loss of drug biotransformation and the protection offered by cysteamine is correlated with the lipid peroxidation activity in hepatic microsomes. The loss of cytochrome P-450 and related drug biotransformation probably is related to the generation of free radicals and subsequent lipid peroxidation in the liver.